Stay updated on Biogen Press Releases

Sign up to get notified when there's something new on the Biogen Press Releases page.
Latest website image capture
Clouds background image

Latest updates to the Biogen Press Releases page

  1. Check
    yesterday
    Change Detected
    Summary
    The page now includes an announcement about Biogen and Stoke Therapeutics presenting data on Zorevunersen for Dravet syndrome at an upcoming congress, while a previous announcement regarding a collaboration with City Therapeutics has been removed.
    Difference
    100%
    Check dated 2025-07-11T17:17:45.000Z thumbnail image
  2. Check
    8 days ago
    Change Detected
    Summary
    The web page has added new core content that includes updated information about pricing and stock availability for key products. Additionally, there are new time slot options available for bookings.
    Difference
    0.3%
    Check dated 2025-07-04T13:03:22.000Z thumbnail image
  3. Check
    15 days ago
    No Change Detected
  4. Check
    22 days ago
    No Change Detected
  5. Check
    29 days ago
    No Change Detected
  6. Check
    44 days ago
    Change Detected
    Summary
    The page has removed the section on Diversity, Equity, & Inclusion, which may indicate a shift in focus or priorities.
    Difference
    1%
    Check dated 2025-05-29T16:00:01.000Z thumbnail image
  7. Check
    87 days ago
    Change Detected
    Summary
    The web page has added a new section or content labeled 'Page 3'.
    Difference
    0.7%
    Check dated 2025-04-16T14:21:19.000Z thumbnail image
  8. Check
    94 days ago
    Change Detected
    Summary
    The page now includes a significant update regarding Biogen's investigational therapy BIIB080, which has received FDA Fast Track Designation for Alzheimer's Disease, while a previous collaboration announcement with Stoke Therapeutics has been removed.
    Difference
    17%
    Check dated 2025-04-09T09:00:20.000Z thumbnail image
  9. Check
    101 days ago
    Change Detected
    Summary
    The page has been updated to include a significant regulatory review update regarding Lecanemab for early Alzheimer's disease, while a previous report on Biogen's financial results has been removed.
    Difference
    10%
    Check dated 2025-04-01T23:11:50.000Z thumbnail image

Stay in the know with updates to Biogen Press Releases

Enter your email address, and we'll notify you when there's something new on the Biogen Press Releases page.